1.
Helbig G, Bober G, Seweryn M, Wichary R, Tukiendorf A, Sedlak L, Oleksy T, Kyrcz-Krzemien S. OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE. Mediterr J Hematol Infect Dis [Internet]. 2015Jan.1 [cited 2020Sep.30];7(1):e2015003. Available from: https://mjhid.org/index.php/mjhid/article/view/2015.003